2H-1-Benzopyran-5-acetic acid, 3,4-dihydro-7-hydroxy-2-methyl-4-oxo-, (S)-

Details

Top
Internal ID 4ae2d2fd-95dc-4bf2-93a4-07d1ec9de853
Taxonomy Organoheterocyclic compounds > Benzopyrans > 1-benzopyrans > Chromones
IUPAC Name 2-[(2S)-7-hydroxy-2-methyl-4-oxo-2,3-dihydrochromen-5-yl]acetic acid
SMILES (Canonical) CC1CC(=O)C2=C(C=C(C=C2O1)O)CC(=O)O
SMILES (Isomeric) C[C@H]1CC(=O)C2=C(C=C(C=C2O1)O)CC(=O)O
InChI InChI=1S/C12H12O5/c1-6-2-9(14)12-7(4-11(15)16)3-8(13)5-10(12)17-6/h3,5-6,13H,2,4H2,1H3,(H,15,16)/t6-/m0/s1
InChI Key MONKQYHCNQSQHL-LURJTMIESA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C12H12O5
Molecular Weight 236.22 g/mol
Exact Mass 236.06847348 g/mol
Topological Polar Surface Area (TPSA) 83.80 Ų
XlogP 0.90
Atomic LogP (AlogP) 1.37
H-Bond Acceptor 4
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
2H-1-Benzopyran-5-acetic acid, 3,4-dihydro-7-hydroxy-2-methyl-4-oxo-, (S)-
94356-37-3

2D Structure

Top
2D Structure of 2H-1-Benzopyran-5-acetic acid, 3,4-dihydro-7-hydroxy-2-methyl-4-oxo-, (S)-

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9386 93.86%
Caco-2 + 0.5483 54.83%
Blood Brain Barrier - 0.7750 77.50%
Human oral bioavailability - 0.5000 50.00%
Subcellular localzation Mitochondria 0.7226 72.26%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8972 89.72%
OATP1B3 inhibitior + 0.9754 97.54%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9626 96.26%
P-glycoprotein inhibitior - 0.9694 96.94%
P-glycoprotein substrate - 0.9038 90.38%
CYP3A4 substrate - 0.5922 59.22%
CYP2C9 substrate - 0.5698 56.98%
CYP2D6 substrate - 0.8487 84.87%
CYP3A4 inhibition - 0.7705 77.05%
CYP2C9 inhibition - 0.6833 68.33%
CYP2C19 inhibition - 0.8897 88.97%
CYP2D6 inhibition - 0.8700 87.00%
CYP1A2 inhibition - 0.7148 71.48%
CYP2C8 inhibition - 0.8838 88.38%
CYP inhibitory promiscuity - 0.9246 92.46%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9213 92.13%
Carcinogenicity (trinary) Non-required 0.6308 63.08%
Eye corrosion - 0.9824 98.24%
Eye irritation + 0.9562 95.62%
Skin irritation - 0.6794 67.94%
Skin corrosion - 0.9229 92.29%
Ames mutagenesis - 0.6244 62.44%
Human Ether-a-go-go-Related Gene inhibition - 0.7471 74.71%
Micronuclear + 0.5759 57.59%
Hepatotoxicity + 0.6125 61.25%
skin sensitisation - 0.8782 87.82%
Respiratory toxicity + 0.5333 53.33%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity + 0.8375 83.75%
Nephrotoxicity - 0.6550 65.50%
Acute Oral Toxicity (c) I 0.5930 59.30%
Estrogen receptor binding - 0.6724 67.24%
Androgen receptor binding + 0.5712 57.12%
Thyroid receptor binding - 0.7988 79.88%
Glucocorticoid receptor binding + 0.6345 63.45%
Aromatase binding - 0.7963 79.63%
PPAR gamma - 0.6350 63.50%
Honey bee toxicity - 0.9385 93.85%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity - 0.6500 65.00%
Fish aquatic toxicity + 0.9215 92.15%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.22% 91.11%
CHEMBL2581 P07339 Cathepsin D 95.80% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.24% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 89.06% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.97% 89.00%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 88.39% 90.71%
CHEMBL3060 Q9Y345 Glycine transporter 2 86.78% 99.17%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 86.18% 85.14%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 85.86% 99.23%
CHEMBL1293249 Q13887 Kruppel-like factor 5 84.85% 86.33%
CHEMBL4208 P20618 Proteasome component C5 82.46% 90.00%

Cross-Links

Top
PubChem 5319543
NPASS NPC123953